Copyright Reports & Markets. All rights reserved.

Global Melphalan Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Melphalan Injection Market Overview

  • 1.1 Product Overview and Scope of Melphalan Injection
  • 1.2 Melphalan Injection Segment by Type
    • 1.2.1 Global Melphalan Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 50mg/vial
    • 1.2.3 10mg/vial
  • 1.3 Melphalan Injection Segment by Application
    • 1.3.1 Melphalan Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Recovery Center
  • 1.4 Global Melphalan Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Melphalan Injection Revenue 2016-2027
    • 1.4.2 Global Melphalan Injection Sales 2016-2027
    • 1.4.3 Melphalan Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Melphalan Injection Market Competition by Manufacturers

  • 2.1 Global Melphalan Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Melphalan Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Melphalan Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Melphalan Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Melphalan Injection Market Competitive Situation and Trends
    • 2.5.1 Melphalan Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Melphalan Injection Players Market Share by Revenue
    • 2.5.3 Global Melphalan Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Melphalan Injection Retrospective Market Scenario by Region

  • 3.1 Global Melphalan Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Melphalan Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Melphalan Injection Market Facts & Figures by Country
    • 3.3.1 North America Melphalan Injection Sales by Country
    • 3.3.2 North America Melphalan Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Melphalan Injection Market Facts & Figures by Country
    • 3.4.1 Europe Melphalan Injection Sales by Country
    • 3.4.2 Europe Melphalan Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Melphalan Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Melphalan Injection Sales by Region
    • 3.5.2 Asia Pacific Melphalan Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Melphalan Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Melphalan Injection Sales by Country
    • 3.6.2 Latin America Melphalan Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Melphalan Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Melphalan Injection Sales by Country
    • 3.7.2 Middle East and Africa Melphalan Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Melphalan Injection Historic Market Analysis by Type

  • 4.1 Global Melphalan Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Melphalan Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Melphalan Injection Price by Type (2016-2021)

5 Global Melphalan Injection Historic Market Analysis by Application

  • 5.1 Global Melphalan Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Melphalan Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Melphalan Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Fresenius Kabi
    • 6.1.1 Fresenius Kabi Corporation Information
    • 6.1.2 Fresenius Kabi Description and Business Overview
    • 6.1.3 Fresenius Kabi Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Fresenius Kabi Product Portfolio
    • 6.1.5 Fresenius Kabi Recent Developments/Updates
  • 6.2 Dr. Reddy's
    • 6.2.1 Dr. Reddy's Corporation Information
    • 6.2.2 Dr. Reddy's Description and Business Overview
    • 6.2.3 Dr. Reddy's Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Dr. Reddy's Product Portfolio
    • 6.2.5 Dr. Reddy's Recent Developments/Updates
  • 6.3 Athenex
    • 6.3.1 Athenex Corporation Information
    • 6.3.2 Athenex Description and Business Overview
    • 6.3.3 Athenex Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Athenex Product Portfolio
    • 6.3.5 Athenex Recent Developments/Updates
  • 6.4 Meitheal Pharmaceutical
    • 6.4.1 Meitheal Pharmaceutical Corporation Information
    • 6.4.2 Meitheal Pharmaceutical Description and Business Overview
    • 6.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Meitheal Pharmaceutical Product Portfolio
    • 6.4.5 Meitheal Pharmaceutical Recent Developments/Updates
  • 6.5 GSK
    • 6.5.1 GSK Corporation Information
    • 6.5.2 GSK Description and Business Overview
    • 6.5.3 GSK Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GSK Product Portfolio
    • 6.5.5 GSK Recent Developments/Updates
  • 6.6 Mylan
    • 6.6.1 Mylan Corporation Information
    • 6.6.2 Mylan Description and Business Overview
    • 6.6.3 Mylan Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Mylan Product Portfolio
    • 6.6.5 Mylan Recent Developments/Updates
  • 6.7 Sagent
    • 6.6.1 Sagent Corporation Information
    • 6.6.2 Sagent Description and Business Overview
    • 6.6.3 Sagent Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sagent Product Portfolio
    • 6.7.5 Sagent Recent Developments/Updates
  • 6.8 Spectrum Pharmaceuticals
    • 6.8.1 Spectrum Pharmaceuticals Corporation Information
    • 6.8.2 Spectrum Pharmaceuticals Description and Business Overview
    • 6.8.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Spectrum Pharmaceuticals Product Portfolio
    • 6.8.5 Spectrum Pharmaceuticals Recent Developments/Updates
  • 6.9 Par Pharmaceuticals
    • 6.9.1 Par Pharmaceuticals Corporation Information
    • 6.9.2 Par Pharmaceuticals Description and Business Overview
    • 6.9.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Par Pharmaceuticals Product Portfolio
    • 6.9.5 Par Pharmaceuticals Recent Developments/Updates
  • 6.10 Mediclone Biotech
    • 6.10.1 Mediclone Biotech Corporation Information
    • 6.10.2 Mediclone Biotech Description and Business Overview
    • 6.10.3 Mediclone Biotech Melphalan Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Mediclone Biotech Product Portfolio
    • 6.10.5 Mediclone Biotech Recent Developments/Updates

7 Melphalan Injection Manufacturing Cost Analysis

  • 7.1 Melphalan Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Melphalan Injection
  • 7.4 Melphalan Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Melphalan Injection Distributors List
  • 8.3 Melphalan Injection Customers

9 Melphalan Injection Market Dynamics

  • 9.1 Melphalan Injection Industry Trends
  • 9.2 Melphalan Injection Growth Drivers
  • 9.3 Melphalan Injection Market Challenges
  • 9.4 Melphalan Injection Market Restraints

10 Global Market Forecast

  • 10.1 Melphalan Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Melphalan Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Melphalan Injection by Type (2022-2027)
  • 10.2 Melphalan Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Melphalan Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Melphalan Injection by Application (2022-2027)
  • 10.3 Melphalan Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Melphalan Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Melphalan Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    50mg/vial
    10mg/vial

    Segment by Application
    Hospital
    Clinics
    Recovery Center

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Fresenius Kabi
    Dr. Reddy's
    Athenex
    Meitheal Pharmaceutical
    GSK
    Mylan
    Sagent
    Spectrum Pharmaceuticals
    Par Pharmaceuticals
    Mediclone Biotech

    Buy now